+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of risperidone on development and expression of nicotine-induced locomotor sensitization in rats



Effects of risperidone on development and expression of nicotine-induced locomotor sensitization in rats



Synapse 65(8): 708-714



It has been shown that atypical antipsychotics significantly reduce smoking and alcohol consumption in schizophrenic patients. However, our knowledge about the effect of risperidone, especially on nicotine abuse is limited. We aimed to test the effects of risperidone in an animal model of nicotine-induced locomotor sensitization, which represents initial neuroadaptations and continued behavioral changes in nicotine-type dependence. To investigate the effect of risperidone on the development of nicotine-induced locomotor sensitization, rats were pretreated with risperidone (0.025 and 0.050 mg kg⁻¹) 30 min before the nicotine (0.5 mg kg⁻¹, base) treatment, and locomotor activity was recorded for 30 min. This procedure was repeated every day for eight sessions. After a 6-day drug-free period, rats were challenged with nicotine (0.5 mg kg⁻¹). To reveal the effect of risperidone on the expression of nicotine-induced locomotor sensitization, rats were injected with nicotine for eight sessions. After a 6-day drug-free period, rats were pretreated with risperidone (0.025 and 0.050 mg kg⁻¹) or vehicle 30 min before the nicotine (0.5 mg kg⁻¹) challenge injection. Repeated administration of nicotine generated robust locomotor sensitization in rats. Risperidone pretreatment (0.050 mg kg⁻¹) blocked the expression but not the development of nicotine-induced locomotor sensitization in rats. Our results suggest that risperidone blocks the continuation of nicotine-type addictive behavior, but it is ineffective on early adaptations in the initiation of nicotine addiction. Thus, this drug may have a limited beneficial effect in treatment of nicotine dependence.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052883977

Download citation: RISBibTeXText

PMID: 21108239

DOI: 10.1002/syn.20886


Related references

Clozapine inhibits development and expression of nicotine-induced locomotor sensitization in rats. Synapse 63(1): 15-21, 2008

Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats. Psychopharmacology 198(4): 461-466, 2008

Mirtazapine attenuates the expression of nicotine-induced locomotor sensitization in rats. European Journal of Pharmacology 812: 28-37, 2017

Low doses of dizocilpine block the development and subsequent expression of locomotor sensitization to nicotine in rats. Psychopharmacology 161(4): 370-378, 2002

Mirtazapine decreased induction and expression of cocaine + nicotine-induced locomotor sensitisation in rats. World Journal of Biological Psychiatry 2019: 1-17, 2019

Pharmacologic antagonism of ghrelin receptors attenuates development of nicotine induced locomotor sensitization in rats. Regulatory Peptides 172(1-3): 77-80, 2011

Inhibitory effect of sowthistle Ixeris dentata on development and expression of behavioral locomotor sensitization to nicotine in rats. Food Science and Biotechnology 21(3): 723-729, 2012

The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats. Addiction Biology 20(2): 248-258, 2015

Concurrent Risperidone Administration Attenuates the Development of Locomotor Sensitization Following Sub-Chronic Phencyclidine in Rats. Pharmacopsychiatry 49(2): 62-65, 2016

The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice. Plos one 8(10): E77284, 2013

Vitexin as an active ingredient in passion flower with potential as an agent for nicotine cessation: vitexin antagonism of the expression of nicotine locomotor sensitization in rats. Pharmaceutical Biology 57(1): 8, 2019

The development and expression of locomotor sensitization to nicotine in the presence of ibogaine. Behavioural Pharmacology 11(5): 431-436, 2000

Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. European Journal of Pharmacology 458(1-2): 111-118, 2003

Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. European Journal of Pharmacology 458(1-2): 111-118, 1 January, 2003

Passion flower extract antagonizes the expression of nicotine locomotor sensitization in rats. Pharmaceutical Biology 50(10): 1310-1316, 2012